Over a 30-day protocol with daily dosing, that single vial gets punctured 30 times, exposed to room temperature 30 times, and receives 30 doses of fresh oxygen
For most patients, discontinuing GLP-1 medications without sustained lifestyle change will lead to weight regain. One semaglutide extension trial found that patients regained roughly two-thirds of their lost weight within a year of stopping treatment
Quick-Reference DDI Summary Table | Co-administered Drug | GLP-1 RA Effect | Clinical Action | |---|---|---| | Insulin (basal) | Additive hypoglycemia | Reduce insulin 20% to 40% at initiation | | Sulfonylurea | Additive hypoglycemia | Halve the dose at initiation | | Warfarin | Possible INR increase | Check INR at 2 to 4 weeks
In a first part, I discuss biological issues related to the persistence of microbial antigens, dysregulated immune responses, reactivation of latent viruses, different potential self-sustained inflammatory loops, mitochondrial dysfunction, metabolic disorders in the tryptophan- kynurenin pathway (TKP) with impact on serotonin, and consequences of a dysfunctional bidirectional microbiota-gut-brain axis
When estrogen declines, that balance shifts
Hydrating cream-based regular sunscreens are more comfortable for dry skin
.png)
